4//SEC Filing
Harrington-Smith Kristen 4
Accession 0001179110-21-010217
CIK 0000855654other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 4:14 PM ET
Size
8.0 KB
Accession
0001179110-21-010217
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Harrington-Smith Kristen
SVP & Chief Commercial Officer
Transactions
- Award
Restricted Stock Unit
2021-11-15+75,000→ 75,000 totalExercise: $0.00From: 2022-11-15→ Common Stock (75,000 underlying) - Award
Common Stock (right to buy)
2021-11-15$5.68/sh+450,000$2,556,000→ 450,000 totalExercise: $5.68From: 2022-11-15Exp: 2032-11-15→ Common Stock (450,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F2]The RSUs vest over a three-year period, with one-third of the RSUs vesting on each of the first three anniversaries of the date of grant, subject to continued service through each vesting date.
- [F3]These options vest over a four-year period, with 25% of the shares vesting on the one year anniversary of the date of grant, and thereafter an additional 6.25% of the shares vesting on each succeeding quarterly anniversary of the date of grant, subject to continued service through each vesting date.
Documents
Issuer
ImmunoGen, Inc.
CIK 0000855654
Entity typeother
Related Parties
1- filerCIK 0001894310
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 4:14 PM ET
- Size
- 8.0 KB